Inspired by Emily Whitehead, along with other early patients treated with investigational CAR-T cell therapy, Novartis embarked on a pioneering journey to reimagine cancer treatment. We’ve helped change the treatment paradigm for thousands of patients; and we continue to relentlessly pursue new science around cell and gene therapies to transform the lives of patients today and in the future.
©2022 Novartis AG